CALCULATE YOUR SIP RETURNS

Health Insurance Fraud Growing in Low and Mid-Value Claims?

Written by: Nikitha DeviUpdated on: 24 Nov 2025, 5:46 pm IST
Fraud in low and mid-value health insurance claims is rising, causing ₹8,000–₹10,000 crore in annual losses and pushing insurers to tighten scrutiny.
Health Insurance
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Health insurers in India are witnessing a sharp increase in fraudulent activity, especially in small and mid-value claims. 

A report by Medi Assist and BCG highlights that fraud risk is highest in claims below ₹50,000 and in the ₹50,000–₹2.5 lakh range, where monitoring is lighter and loopholes are more easily exploited.

Fraud Rising in Low-Ticket Claims

Insurers note that claims under ₹50,000 have silently become a significant fraud hotspot. These claims generally pass with minimal paperwork and fewer verification layers, creating scope for inflated consumables, billing for services not provided, or multiple small claims that evade detection. Fraud in this segment has steadily increased over the last three years.

Mid-Value Claims Pose Higher Risk

The report finds that claims between ₹50,000 and ₹2.5 lakh carry the highest fraud propensity. This range offers enough financial incentive for manipulation while still operating under moderate scrutiny.

Many routine procedures fall within this band, making it easier to inflate bills, alter codes, or add unnecessary tests without triggering stringent checks. Claims above ₹2.5 lakh require pre-authorisation and extensive documentation, reducing manipulation opportunities.

Impact on Insurers and Policyholders

Industry estimates show that 8–10% of total claim payouts are lost annually to fraud, waste, and abuse, amounting to ₹8,000–₹10,000 crore in leakages. These losses directly affect insurer profitability and contribute to higher premiums for customers. Behavioural factors also play a role, with small-ticket fraud often perceived as insignificant, enabling misuse across the healthcare ecosystem.

Higher Misuse in Infectious Disease Claims

The study indicates that claims linked to infectious diseases show disproportionately high fraud risk. Their generic symptoms, extensive testing, and difficulty in verifying actual treatment make them more prone to misuse.

Meanwhile, surgical claims carry lower fraud risk due to mandatory approvals, involvement of multiple specialists, and detailed documentation.

Also ReadOctober Insurance Data Reflects Mixed Trends!

Conclusion

The report underscores the need for fraud detection systems, improved analytics, and stricter claim verification, particularly for low and mid-value claims. Strengthening these checks is essential to reduce leakages and help maintain fair premium levels for policyholders.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Published on: Nov 24, 2025, 12:15 PM IST

Nikitha Devi

Nikitha is a content creator with 7+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers